Little Green Pharma announced its wholly owned subsidiary, Little Green Pharma Denmark ApS, has entered into an agreement
with Cannamedical Pharma for the bulk supply of a high-THC strain into Germany.
The Agreement represents LGP’s fourth contract for the supply of medicinal cannabis into Germany and, together with Four20 Pharma, Illios Sante, and Demecan, rounds out its wholesaling portfolio with the
largest independent, own-brand medicinal cannabis distributor in Germany.
Under the Agreement, LGP will exclusively supply the Product to Cannamedical for sale in Germany subject to Cannamedical ordering
specified minimum quantities every six months to maintain exclusivity. In addition, the Product pricing contemplates a THC adjustment for every percentage point the THC content is above or below 22%,
and with the payment terms requiring the upfront payment of a portion of the purchase price upon delivery.
For more information:
Little Green Pharma
[email protected]
littlegreenpharma.com
Sign up for our daily Newsletter and stay up to date with all the latest news!
Subscribe I am already a subscriber